Global Intravenous-to-Subcutaneous Drugs Market Research Report 2021

August 2016 | 109 pages | ID: G696095426FEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Intravenous-to-Subcutaneous Drugs

Revenue, means the sales value of Intravenous-to-Subcutaneous Drugs

This report studies Intravenous-to-Subcutaneous Drugs in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• Amgen
• AstraZeneca
• Baxter
• Britannia
• Capricor
• CSL Behring
• GlaxoSmithKline
• Grifols
• Ferring
• Janssen
• NeuroDerm
• Octapharma
• Roche
• Rhythm Metabolic
• scPharmceuticals
• SteadyMed
• Takeda
• United Therapeutics
• UCB
• US Worldmeds

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Intravenous-to-Subcutaneous Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Intravenous-to-Subcutaneous Drugs in each application, can be divided into

• Medical care
• Hospital
• Application 3

Contents

Global Intravenous-to-Subcutaneous Drugs Market Research Report 2021

1 INTRAVENOUS-TO-SUBCUTANEOUS DRUGS OVERVIEW

1.1 Product Overview and Scope of Intravenous-to-Subcutaneous Drugs
1.2 Intravenous-to-Subcutaneous Drugs Segment by Types
  1.2.1 Global Sales Market Share of Intravenous-to-Subcutaneous Drugs by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Intravenous-to-Subcutaneous Drugs Segment by Applications
  1.3.1 Medical care
  1.3.2 Hospital
  1.3.3 Application
1.4 Intravenous-to-Subcutaneous Drugs Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Intravenous-to-Subcutaneous Drugs (2011-2021)
  1.5.1 Global Intravenous-to-Subcutaneous Drugs Sales and Revenue (2011-2021)
  1.5.2 Global Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
  1.5.3 Global Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Intravenous-to-Subcutaneous Drugs Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Intravenous-to-Subcutaneous Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Intravenous-to-Subcutaneous Drugs Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUGS ANALYSIS BY REGION

3.1 Global Intravenous-to-Subcutaneous Drugs Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Intravenous-to-Subcutaneous Drugs Sales Market Share by Region (2011-2021)
  3.1.2 Global Intravenous-to-Subcutaneous Drugs Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
  3.2.2 North America Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
  3.4.2 China Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
  3.6.2 India Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUGS ANALYSIS BY TYPE

4.1 Global Intravenous-to-Subcutaneous Drugs Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Intravenous-to-Subcutaneous Drugs Sales and Market Share by Type (2011-2021)
  4.1.2 Global Intravenous-to-Subcutaneous Drugs Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type I Sales, Revenue, Price and Growth (2011-2020)
4.3 Type II Sales, Revenue, Price and Growth (2011-2020)
4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUGS MARKET ANALYSIS BY APPLICATION

5.1 Global Intravenous-to-Subcutaneous Drugs Sales and Market Share by Application (2011-2021)
5.2 Major Regions Intravenous-to-Subcutaneous Drugs Sales by Application in 2015 and 2016
  5.2.1 North America Intravenous-to-Subcutaneous Drugs Sales by Application
  5.2.2 Europe Intravenous-to-Subcutaneous Drugs Sales by Application
  5.2.3 China Intravenous-to-Subcutaneous Drugs Sales by Application
  5.2.4 Japan Intravenous-to-Subcutaneous Drugs Sales by Application
  5.2.5 India Intravenous-to-Subcutaneous Drugs Sales by Application
  5.2.6 Southeast Asia Intravenous-to-Subcutaneous Drugs Sales by Application

6 GLOBAL INTRAVENOUS-TO-SUBCUTANEOUS DRUGS MANUFACTURERS ANALYSIS

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.1.2.1 Type I
    6.1.2.2 Type II
    6.1.2.3 Type III
  6.1.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Amgen (2015 and 2016)
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.2.2.1 Type I
    6.2.2.2 Type II
    6.2.2.3 Type III
  6.2.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of AstraZeneca (2015 and 2016)
6.3 Baxter
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.3.2.1 Type I
    6.3.2.2 Type II
    6.3.2.3 Type III
  6.3.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Baxter (2015 and 2016)
6.4 Britannia
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.4.2.1 Type I
    6.4.2.2 Type II
  6.4.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Britannia (2015 and 2016)
6.5 Capricor
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.5.2.1 Type I
    6.5.2.2 Type II
  6.5.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Capricor (2015 and 2016)
6.6 CSL Behring
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.6.2.1 Type I
    6.6.2.2 Type II
  6.6.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of CSL Behring (2015 and 2016)
6.7 GlaxoSmithKline
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.7.2.1 Type I
    6.7.2.2 Type II
  6.7.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
6.8 Grifols
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.8.2.1 Type I
    6.8.2.2 Type II
  6.8.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Grifols (2015 and 2016)
6.9 Ferring
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.9.2.1 Type I
    6.9.2.2 Type II
  6.9.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Ferring (2015 and 2016)
6.10 Janssen
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Intravenous-to-Subcutaneous Drugs Product Overview
    6.10.2.1 Type I
    6.10.2.2 Type II
  6.10.3 Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Janssen (2015 and 2016)
6.11 NeuroDerm
6.12 Octapharma
6.13 Roche
6.14 Rhythm Metabolic
6.15 scPharmceuticals
6.16 SteadyMed
6.17 Takeda
6.18 United Therapeutics
6.19 UCB
6.20 US Worldmeds

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Intravenous-to-Subcutaneous Drugs
Figure Global Sales Market Share of Intravenous-to-Subcutaneous Drugs by Type in 2015
Table Intravenous-to-Subcutaneous Drugs Product Type of by Manufacturers
Table Intravenous-to-Subcutaneous Drugs Sales Market Share by Application in 2015 and 2016
Figure North America Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure China Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure India Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales and Revenue (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales and Growth Rate (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Revenue and Growth Rate (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales of Key Manufacturers (2015 and 2016)
Table Global Intravenous-to-Subcutaneous Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Intravenous-to-Subcutaneous Drugs Sales Share by Manufacturers
Figure 2016 Intravenous-to-Subcutaneous Drugs Sales Share by Manufacturers
Table Global Intravenous-to-Subcutaneous Drugs Revenue by Manufacturers (2015 and 2016)
Table Global Intravenous-to-Subcutaneous Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Intravenous-to-Subcutaneous Drugs Revenue Share by Manufacturers
Table 2016 Global Intravenous-to-Subcutaneous Drugs Revenue Share by Manufacturers
Table Manufacturers Intravenous-to-Subcutaneous Drugs Manufacturing Base Distribution and Product Type
Table Global Intravenous-to-Subcutaneous Drugs Sales Market by Region (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales Market by Region (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales Market Share by Region (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Revenue Market by Region (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Revenue Market Share by Region (2011-2021)
Table North America Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
Figure North America Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
Table Europe Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
Figure Europe Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
Table China Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
Figure China Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
Table Japan Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
Figure Japan Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
Table India Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
Figure India Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Intravenous-to-Subcutaneous Drugs Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Intravenous-to-Subcutaneous Drugs Sales, Revenue and Growth Rate (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales by Type (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales Share by Type (2011-2021)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drugs by Type (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales Growth Rate by Type (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Revenue by Type (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Revenue Share by Type (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Revenue Growth Rate by Type (2011-2021)
Figure Type I Sales, Revenue and Growth (2011-2021)
Figure Type I Price Trend (2011-2021)
Figure Type II Sales, Revenue and Growth (2011-2021)
Figure Type II Price Trend (2011-2021)
Figure Type III Sales, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales by Application (2011-2021)
Table Global Intravenous-to-Subcutaneous Drugs Sales Market Share by Application (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales Market Share by Application in 2015
Figure Global Intravenous-to-Subcutaneous Drugs Sales Market Share by Application in 2021
Table North America Intravenous-to-Subcutaneous Drugs Sales by Application (2015 and 2016)
Table Europe Intravenous-to-Subcutaneous Drugs Sales by Application (2015 and 2016)
Table China Intravenous-to-Subcutaneous Drugs Sales by Application (2015 and 2016)
Table Japan Intravenous-to-Subcutaneous Drugs Sales by Application (2015 and 2016)
Table India Intravenous-to-Subcutaneous Drugs Sales by Application (2015 and 2016)
Table Southeast Asia Intravenous-to-Subcutaneous Drugs Sales by Application (2015 and 2016)
Table Global Intravenous-to-Subcutaneous Drugs Sales Growth Rate by Application (2011-2021)
Figure Global Intravenous-to-Subcutaneous Drugs Sales Growth Rate by Application (2011-2021)
Table Amgen Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Amgen (2015 and 2016)
Table AstraZeneca Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Baxter Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Baxter (2015 and 2016)
Table Britannia Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Britannia (2015 and 2016)
Table Capricor Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Capricor (2015 and 2016)
Table CSL Behring Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of CSL Behring (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Grifols Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Grifols (2015 and 2016)
Table Ferring Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Ferring (2015 and 2016)
Table Janssen Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Janssen (2015 and 2016)
Table NeuroDerm Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of NeuroDerm (2015 and 2016)
Table Octapharma Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Octapharma (2015 and 2016)
Table Roche Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Roche (2015 and 2016)
Table Rhythm Metabolic Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Rhythm Metabolic (2015 and 2016)
Table scPharmceuticals Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of scPharmceuticals (2015 and 2016)
Table SteadyMed Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of SteadyMed (2015 and 2016)
Table Takeda Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of Takeda (2015 and 2016)
Table United Therapeutics Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of United Therapeutics (2015 and 2016)
Table UCB Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of UCB (2015 and 2016)
Table US Worldmeds Basic Information List
Table Intravenous-to-Subcutaneous Drugs Sales, Revenue, Price of US Worldmeds (2015 and 2016)